Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Seaport Therapeutics, Inc (SPTX) had Income from Continuous Operations of $-26.39M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
-- |
|
$-26.39M |
|
-- |
|
-- |
|
$30.34M |
|
$-30.34M |
|
$4.08M |
|
$-26.27M |
|
$-26.27M |
|
$-26.39M |
|
|
Income from Continuous Operations |
$-26.39M |
$-26.39M |
|
$-26.39M |
|
$-30.34M |
|
$-30.54M |
|
53.53M |
|
53.53M |
|
$-0.49 |
|
$-0.49 |
|
| Balance Sheet Financials | |
$299.06M |
|
$0.33M |
|
$118.56M |
|
$417.62M |
|
$17.11M |
|
-- |
|
$3.06M |
|
$20.17M |
|
$397.45M |
|
$397.45M |
|
$397.45M |
|
53.53M |
|
| Cash Flow Statement Financials | |
$-69.00M |
|
$-155.54M |
|
$240.05M |
|
$46.50M |
|
$62.01M |
|
$15.51M |
|
$41.88M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-69.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.64% |
|
-6.64% |
|
-6.32% |
|
-6.64% |
|
$7.42 |
|
$-1.29 |
|
$-1.29 |
|